Back
ESC2025 Premium Access

Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

Session: Cardiovascular and limb outcomes in peripheral artery disease
Topic: Peripheral Artery Disease
Speaker: Professor J. Nordanstig (Gothenburg, SE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Joakim Nordanstig

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)
1 presentation
0 follower

4 more presentations in this session

Intensity of glycemic control and risk of cardiovascular and limb events in peripheral artery disease

Speaker: Associate Professor S. Girotra (Dallas, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Predictors of wound recurrence after wound healing in patients with chronic limb-threatening ischemia.

Speaker: Doctor K. Ukai (Osaka, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Causal effect of hair color in atherosclerotic cardiovascular disease: a two-sample Mendelian randomization study

Speaker: Doctor Y. Zheng (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Three-year outcome after coronary stenting in all-comer patients: Impact of diabetes and peripheral arterial disease

Speaker: Ms D. van Vliet (Enschede, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiovascular and limb outcomes in peripheral artery disease

Speakers: Professor J. Nordanstig, Associate Professor S. Girotra, Doctor K. Ukai, Doctor Y. Zheng, Ms D. van Vliet
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources